SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10QSB - Optional form for quarterly and transition reports of small business issuers:
SEC Accession No. 0000812796-04-000036
Filing Date
2004-11-15
Accepted
2004-11-15 17:17:25
Documents
6
Period of Report
2004-09-30

Document Format Files

Seq Description Document Type Size
1 10QSB-3Q-2004 q103q2004.htm 10QSB 314361
2 EX-31.1 ex31w1.htm EX-31 11599
3 EX-31W2 ex31w2.htm EX-31.2 11481
4 EX-32.1 ex32w1.htm EX-32.1 7186
5 EX-32.2 ex32w2.htm EX-32.2 7435
6 EX99.1 RISK FACTORS ex99w1r.htm EX-99.1 R 51350
  Complete submission text file 0000812796-04-000036.txt   405675
Mailing Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139
Business Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139 305-534-3383
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10QSB | Act: 34 | File No.: 000-16929 | Film No.: 041146782
SIC: 2834 Pharmaceutical Preparations